Original Article from The New England Journal of Medicine — Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Fonte: Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis | NEJM
Artigo médico
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM
Original Article from The New England Journal of Medicine — Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
Fonte: Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM
Original Article from The New England Journal of Medicine — Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Fonte: Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM
A integra do artigo da NEJM do post anterior
Another JAK Inhibitor Shows Mortality Benefit in COVID-19 | MedPage Today
Tofacitinib cut incidence of severe outcomes in a population where most received steroids
Fonte: Another JAK Inhibitor Shows Mortality Benefit in COVID-19 | MedPage Today
Neurologic Disease after Yellow Fever Vaccination, São Paulo, Brazil, 2017–2018 – Volume 27, Number 6—June 2021 – Emerging Infectious Diseases journal – CDC
Disease should be diagnosed by using the Brighton Collaboration case definitions and cerebrospinal fluid IgM reactivity.
Publicação com a participação do nosso contemporâneo de residência, Dr. Augusto Penalva
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM
Original Article from The New England Journal of Medicine — Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Fonte: Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM
Síndrome pós-aguda por Covid-19
Artigo da nature.
Síndrome pós-aguda COVID-19
Uma revisão abrangente da literatura atual sobre COVID-19 pós-aguda, a sua patofisiologia e as suas sequelas específicas para os órgãos.
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives
Nature: SARS-CoV-2 receptor is co-expressed with elements of the kinin–kallikrein, renin–angiotensin and coagulation systems in alveolar cells
SARS-CoV-2, the pathogenic agent of COVID-19, employs angiotensin converting enzyme-2 (ACE2) as its cell entry receptor. Clinical data reveal that in severe COVID-19, SARS-CoV-2 infects the lung, leading to a frequently lethal triad of respiratory insufficiency, acute cardiovascular failure, and coagulopathy.
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients | European Respiratory Society
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients | European Respiratory Society
— Ler em erj.ersjournals.com/content/56/4/2001811
blog infectologia em geral 